Petrenko Valery A
Department of Pathobiology, College of Veterinary Medicine, Auburn University, 253 Greene Hall, AL 36849-5519, USA.
Ther Deliv. 2017 Dec;8(12):1063-1075. doi: 10.4155/tde-2017-0086.
Low efficacy of targeted nanomedicines in biological experiments enforced us to challenge the traditional concept of drug targeting and suggest a paradigm of 'addressed self-navigating drug-delivery vehicles,' in which affinity selection of targeting peptides and vasculature-directed in vivo phage screening is replaced by the migration selection, which explores ability of 'promiscuous' phages and their proteins to migrate through the tumor-surrounding cellular barriers, using a 'hub and spoke' delivery strategy, and penetrate into the tumor affecting the diverse tumor cell population. The 'self-navigating' drug-delivery paradigm can be used as a theoretical and technical platform in design of a novel generation of molecular medications and imaging probes for precise and personal medicine. [Formula: see text].
靶向纳米药物在生物学实验中的低效性促使我们挑战传统的药物靶向概念,并提出一种“寻址自导航药物递送载体”的范式。在这种范式中,靶向肽的亲和力选择和体内血管导向噬菌体筛选被迁移选择所取代,迁移选择利用“中心辐射”递送策略探索“混杂”噬菌体及其蛋白质穿过肿瘤周围细胞屏障并渗透到肿瘤中影响不同肿瘤细胞群体的能力。“自导航”药物递送范式可作为新一代分子药物和成像探针设计的理论和技术平台,用于精准和个性化医疗。[公式:见原文]